Loading stock data…
UNH
$365.81-4.95 (-1.33%)
Market OpenUpdated 10:27 AM EDT
UnitedHealth Group Incorporated operates as a health care company in the United States and internationally.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
UnitedHealth Group Incorporated in the Healthcare sector is trading at $369.48. The stock is currently 9% below its 52-week high of $404.72, remaining 18.1% above its 200-day moving average. Technical signals show overbought RSI of 93 and bullish MACD crossover, explaining why UNH maintains its current momentum and trend strength. The Whystock Score of 55/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Overbought levels (RSI 93) — risk of consolidation or pullback
Long-term trend bullish (Price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
JNJPFEABBV
Whystock Valuation Model
Whystock fair value is estimated using a trailing P/E model adjusted for return on equity: Fair P/E = 18 + (ROE × 20). Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. A base P/E of 18 represents a typical market multiple, scaled upward for companies that earn high returns on equity. The result is a theoretical "normalised" price — not a price target or investment advice. Large deviations are common for high-growth or loss-making companies.
Current Price$365.81
Potential Downside
15.8%
Whystock Fair Value$308.14
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Analyst Consensus26 analysts
Buy
Mean target$387.27+5.9%
Range$287.00 – $444.00
Fundamentals
UnitedHealth Group Incorporated operates as a health care company in the United States and internationally. It operates through four segments: Optum Health, Optum Insight, Optum Rx; and UnitedHealthcare. The Optum Health segment provides care deliver...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$321.07B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
26.74
Beta
Defensive asset. Lower volatility than the S&P 500.
0.41
Div Yield
Strong income play. Yield provides a meaningful total return floor.
250.00%
ROE
Elite ROE. Management converts capital into profit efficiently.
22.63%
Volume
Today's trading volume
928,191
Recent News
UnitedHealth to Make It Easier for Patients to Get a Range of Procedures
Insurer will reduce required authorizations by 30%, easing access to some tests, surgeries and therapy.
How Investors Are Reacting To UnitedHealth Group (UNH) Earnings Beat, Guidance Hike and Governance Challenge
In April 2026, UnitedHealth Group reported first-quarter 2026 results showing revenue of US$111.72 billion and net income of US$6.28 billion, while also facing a shareholder proposal from The Accountability Board to require an independent Board Chair, which the company’s proxy statement urged investors to vote against. This mix of steady financial performance and a governance challenge highlights how UnitedHealth’s board structure and oversight practices are coming under closer investor...
Acadia Healthcare Q1 Earnings Beat Estimates on Rising Patient Days
ACHC Q1 tops estimates with 37 cents EPS and 7.6% revenue growth, driven by higher patient days and admissions despite shorter stays and rising costs.
Select Medical Q1 Earnings Miss Estimates on Higher Expenses
SEM's Q1 EPS misses due to higher expenses and weaker patient days, even as revenues top estimates and rehab segment growth partly offsets pressure.
TDOC Q1 Earnings Miss, Revenues Down Y/Y on BetterHelp Weakness
Teladoc Health posts a y/y narrower Q1 loss and beats revenue estimates as international growth and cost cuts offset BetterHelp weakness and subscription declines.